AMG GW&K Small Cap Value Z holds a quantitatively derived Negative Morningstar Medalist Rating. The rating indicates the model sees limited potential for the strategy to outperform peers on a risk-adjusted basis over a full market cycle.
AMG GW&K Small Cap Value Fund Class Z SKSZX
- NAV / 1-Day Return 34.32 / +1.33 %
- Total Assets 218.5M
-
Adj. Expense Ratio
0.900%
- Expense Ratio 0.880%
- Distribution Fee Level Average
- Share Class Type Institutional
- Category Small Blend
- Investment Style Small Value
- Min. Initial Investment 5M
- Status Open
- TTM Yield 0.73%
- Turnover 36%
USD | NAV as of Oct 03, 2026 | 1-Day Return as of Oct 03, 2026, 12:34 AM GMT+0
Morningstar’s Analysis SKSZX
Will SKSZX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 20.3
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Ligand Pharmaceuticals Inc | 3.02 | 7M | Healthcare |
Imax Corp | 2.52 | 6M | Communication Services |
Ducommun Inc | 2.34 | 5M | Industrials |
Ameris Bancorp | 1.93 | 4M | Financial Services |
Federal Agricultural Mortgage Corp Class C | 1.91 | 4M | Financial Services |
NeoGenomics Inc | 1.81 | 4M | Healthcare |
UMB Financial Corp | 1.76 | 4M | Financial Services |
Integer Holdings Corp | 1.67 | 4M | Healthcare |
ManpowerGroup Inc | 1.66 | 4M | Industrials |
Supernus Pharmaceuticals Inc | 1.64 | 4M | Healthcare |